Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Trends in Cancer Research   Volumes    Volume 13 
Current trends in immunotherapy for multiple myeloma
Samer A. Srour, Qaiser Bashir, Muzaffar H. Qazilbash
Pages: 79 - 97
Number of pages: 19
Trends in Cancer Research
Volume 13 

Copyright © 2018 Research Trends. All rights reserved

Multiple myeloma is characterized by severe immune dysfunction related to the malignant plasma cells and the bone marrow microenvironment. With advances in cancer immunology, the landscape of anti-cancer treatment has been revolutionized over the last several years. Several immunotherapy-based strategies have been investigated in myeloma, some showing significant activity, while others are still being studied in earlier phases of clinical trials. Immunotherapeutic modalities being explored in myeloma can be divided into active immunotherapeutic strategies, such as tumor vaccines and checkpoint inhibitors that stimulate the endogenous immune response, and passive approaches such as monoclonal antibodies and adoptive cellular therapy, where ex vivo-generated antibodies or activated cells target myeloma. In this review, we will summarize various immunotherapy-based strategies being employed in multiple myeloma to date, with a special focus on treatments with proven efficacy and future promise.
View Full Article  


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms